Scarica l'app Stockscreener
25.46
7.56%
1.79
Pre-mercato:
26.31
0.85
+3.34%
Pulse Biosciences Inc Borsa (PLSE) Ultime notizie
A Glimpse of Pulse Biosciences's Earnings Potential - Benzinga
Pulse Biosciences CCO Danahy sells $1.41 million in stock By Investing.com - Investing.com Nigeria
Pulse Biosciences CCO Danahy sells $1.41 million in stock - Investing.com
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a Potential 12.99% Upside in the Healthcare Sector - DirectorsTalk Interviews
Will Pulse Biosciences Inc. stock continue dividend increases2025 Market WrapUp & Long Hold Capital Preservation Tips - mfd.ru
Is Pulse Biosciences Inc. affected by consumer sentimentTreasury Yields & Community Consensus Stock Picks - mfd.ru
Can Pulse Biosciences Inc. sustain its profitability2025 Technical Patterns & Verified Technical Trade Signals - mfd.ru
Pulse Biosciences (NASDAQ:PLSE) Shares Down 9.2% Following Insider Selling - MarketBeat
PLSE shares positive first-in-human nPulse cardiac catheter data - MSN
Pulse Biosciences (PLSE) to Release Earnings on Thursday - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Insider Kevin Patrick Danahy Sells 20,000 Shares - MarketBeat
Kevin Patrick Danahy Sells 20,000 Shares of Pulse Biosciences (NASDAQ:PLSE) Stock - MarketBeat
Pulse Biosciences (NASDAQ:PLSE) Stock Price Up 7.5%Here's What Happened - MarketBeat
Is Pulse Biosciences Inc. stock a good pick for beginners2025 Pullback Review & Consistent Income Trade Recommendations - mfd.ru
Pulse Biosciences (PLSE) Is Up 70.4% After Strong First-in-Human nPulse AF Data Release – Has The Bull Case Changed? - Sahm
Why Pulse Biosciences Inc. (6L8) stock could break out in 2025Trade Entry Report & High Win Rate Trade Alerts - mfd.ru
Pulse Biosciences, Inc. (PLSE) Stock Analysis: Riding a Wave of Innovation with a 7.39% Upside Potential - DirectorsTalk Interviews
Pulse Biosciences (NASDAQ:PLSE) Hits New 52-Week HighWhat's Next? - MarketBeat
Pulse Biosciences stock hits 52-week high at 22.76 USD By Investing.com - Investing.com South Africa
Pulse Biosciences stock hits 52-week high at 22.76 USD - Investing.com Nigeria
Pulse Biosciences (NASDAQ:PLSE) Sees Strong Trading VolumeShould You Buy? - MarketBeat
PLSE Shares Positive First-in-Human nPulse Cardiac Catheter Data - TradingView
Abbott details Volt, TactiFlex data; Pulse Biosciences’ results shine - MedTech Dive
Pulse Biosciences Highlights Strong AF Outcomes From NPulse Feasibility Study - Nasdaq
A Look At Pulse Biosciences (PLSE) Valuation After Its Recent Share Price Surge - Sahm
Precision Trading with Pulse Biosciences Inc (PLSE) Risk Zones - Stock Traders Daily
We're Not Very Worried About Pulse Biosciences' (NASDAQ:PLSE) Cash Burn Rate - Yahoo Finance
Pulse Biosciences Stock Pre-Market (+5.5%): Searching for a Catalyst - Trefis
Pulse Biosciences Heart Device Data Fuels Stock Surge - Benzinga
Top Midday Gainers - marketscreener.com
Pulse Biosciences (NASDAQ:PLSE) Shares Gap UpHere's What Happened - MarketBeat
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Pulse Biosciences stock rises after positive cardiac catheter study data By Investing.com - Investing.com Canada
Pulse Biosciences, Inc. Announces nPulse Cardiac Catheter Study Results - TradingView
Pulse Biosciences Shares Rise as Cardiac Catheter Feasibility Study Shows Successful Atrial Fibrillation Treatment - marketscreener.com
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardia - The National Law Review
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - MEXC
Pulse Biosciences Achieves Success in Cardiac Catheter Study - Intellectia AI
Pulse Biosciences (PLSE) Reports Promising Clinical Data from Ca - GuruFocus
Pulse Biosciences Presents Late-Breaking Data from nPulse Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium - Investing News Network
AF heart study in 150 patients reports 96% success at 1 year - Stock Titan
Maria Sainz Joins Pulse Biosciences Board of Directors - Medical Product Outsourcing
Pulse Biosciences Schedules Fourth Quarter & Full Year 2025 Financial Results Conference Call for February 19, 2026 - The Joplin Globe
Pulse Biosciences’ nPulse™ Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - BioSpace
Analyst Calls: How does TELA correlate with NasdaqPortfolio Update Summary & Stock Market Timing Techniques - baoquankhu1.vn
Pulse Biosciences' nPulse Cardiac Catheter to Be Featured in Multiple Presentations at the AF Symposium - Investing News Network
Mizuho Initiates Coverage on Pulse Biosciences (NASDAQ:PLSE) - Defense World
Mizuho Securities Initiates Coverage on Pulse Biosciences With Outperform Rating - marketscreener.com
Mizuho initiates Pulse Biosciences stock with Outperform rating, $25 target By Investing.com - Investing.com Canada
Does Pulse Biosciences Inc. have strong fundamentalsJuly 2025 Volume & Momentum Based Trading Ideas - mfd.ru
Technical Reactions to PLSE Trends in Macro Strategies - Stock Traders Daily
Gap Down: Is Pulse Biosciences Inc exposed to currency risksJuly 2025 Weekly Recap & High Conviction Trade Alerts - baoquankhu1.vn
Day Trade: Does Assured Guaranty Ltd outperform in volatile marketsQuarterly Earnings Report & Long-Term Growth Plans - baoquankhu1.vn
Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring A 53% Upside Potential - DirectorsTalk Interviews
Aug Outlook: Is Tiziana Life Sciences Ltd likely to announce a buybackMarket Sentiment Summary & Precise Buy Zone Tips - baoquankhu1.vn
Pulse Biosciences (NASDAQ:PLSE) & Autonomix Medical (NASDAQ:AMIX) Financial Contrast - Defense World
Jobs Data: Can Pulse Biosciences Inc sustain earnings growthRecession Risk & Weekly High Return Stock Forecasts - baoquankhu1.vn
Geopolitics Watch: Should I trade or invest in Pulse Biosciences Inc2025 Market Sentiment & Smart Allocation Stock Tips - baoquankhu1.vn
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):